29Apr 2021
Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study

Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study

To evaluate the effects of long-term tumor necrosis factor (TNF) inhibition on the risk and age at onset of Parkinson disease (PD), we performed a 2-sample Mendelian randomization study using genome-wide association studies (GWAS) summary statistics...

  • #neurology

Like

Save

Share